MARKET

LCI

LCI

Lannet Inc
NYSE
0.4629
-0.0055
-1.17%
After Hours: 0.4600 -0.0029 -0.63% 17:56 09/29 EDT
OPEN
0.4600
PREV CLOSE
0.4684
HIGH
0.4799
LOW
0.4502
VOLUME
57.81K
TURNOVER
0
52 WEEK HIGH
3.200
52 WEEK LOW
0.4300
MARKET CAP
19.89M
P/E (TTM)
-0.0808
1D
5D
1M
3M
1Y
5Y
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Benzinga · 09/20 07:16
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Benzinga · 09/19 16:29
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 09/19 12:44
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
Gainers FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday.
Benzinga · 09/19 10:53
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Benzinga · 09/19 05:53
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 09/16 18:06
BRIEF-Lannett Completes Subject Dosing For Clinical Trial Of Biosimilar Insulin Glargine
BRIEF-Lannett Completes Subject Dosing For Clinical Trial Of Biosimilar Insulin Glargine
Reuters · 08/31 11:25
Lannett Completes Dosing of Patients in Clinical Trial of Biosimilar Insulin Glargine
Lannett Completes Dosing of Patients in Clinical Trial of Biosimilar Insulin Glargine
MT Newswires · 08/31 07:11
More
About LCI
Lannett Company, Inc. is engaged in the development, manufacturing, marketing and distribution of generic versions of brand pharmaceutical products. The Company markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company’s product portfolio include Amphetamine IR Tablets, which are used to treat Attention deficit hyperactivity disorder (ADHD) and narcolepsy; Dicyclomine tablets, used for the treatment of functional bowel disorder and irritable bowel syndrome; Levothyroxine Capsules, used to treat patients with hypothyroidism and other conditions, and Numbrino Nasal Solution, used for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults, among others.

Webull offers kinds of Lannett Company, Inc. stock information, including NYSE:LCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LCI stock methods without spending real money on the virtual paper trading platform.